Epidemiology of breast cancer;Epidemiología del cáncer de mama

Ginecologia y Obstetricia de Mexico

Volumn 74, Issue 11, 2006, Pages 585-593

  Rodríguez Cuevas, Sergio A ^a,b,c,d,f   García, Marino Capurso ^a,e  

^a Inst de Enferm de la Mama de la Fund   (Mexico)

^b HOSPITAL DE ONCOLOGÍA   (Mexico)

^c Academia Mexicana de Cirugia AC   (Mexico)

^d Unidad Durango   (Mexico)

^e Asociación Mexicana de Mastología

^f NONE   (Mexico)

Author keywords

Breast cancer; Epidemiology

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; HUMAN; MAMMOGRAPHY; MORTALITY; SURVIVAL RATE; ADULT; AGED; BREAST TUMOR; FEMALE; MEXICO; MIDDLE AGED; REVIEW; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MEXICO; MIDDLE AGED; RISK FACTORS;

EID: 34250613581     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. International Agency for Research on Cancer. World Health Organization. Lyon: IARC Press, 2002.
2. Mettlin C. Global breast cancer mortality statistics. CA Cancer J Clin 1999;49:138-44.
3. Compendio del registro histopatológico de neoplasias en México. Morbilidad y mortalidad. México: Secretaría de Salud, 1999.
4. Rodríguez-Cuevas SA, Labastida SA, Tapia R, Kuri P, Macías C. Registro histopatológico de neoplasias en México. Población derechohabiente del IMSS 1991-1996. México: Ciencia y Cultura Latinoamericana, 1999;p:56.
5. Ries LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK, editors. SEER Cancer Statistics Review, 1973-1995. Bethesda: National Cancer Institute, 1998.
6. Chu KC, Tarone R, Kessler L, et al. Recent trends in US breast cancer incidence, survival and mortality rates. J Natl Cancer Inst 1996;88:1571-9.
7. La Vecchia C, Negri E, Levi F, Decarli A. Age, cohort of birth, and period of death trends in breast cancer mortality in Europe. J Natl Cancer Inst 1997;89:732-4.
8. Jemal A, Murray T, Samuels A, et al. Cancer Statistics 2003. CA Cancer J Clin 2003;53:5-26.
9. Rodríguez-Cuevas S, Macías CG, Franceschi D, Labastida S. Breast carcinoma presents a decade earlier in Mexican women than in women in the United Status or European countries. Cancer 2001;91:863-8.
10. Hoskins KF, Stopfer JE, Calzone KA, et al. Assesment and counseling for women with a family history of breast cancer. A guide to clinicians. JAMA 1995;273:577-85.
11. Futreal P, Liu Q, Shattuck-Gidens D, et al. BRCA 1 mutation in breast an ovary carcinomas. Science 1994;226:120-2.
12. Wooster R, Neuhausen S, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA 2, to chromosome 13q12-13. Science 1994;265:2088-90.
13. Rivera-Claise E, Rodríguez-Cuevas SA, Luna Pérez P. Epidemiología y aspectos genéticos del cáncer de mama. Cir Gral 1997;19:180-6.
14. Dupont DW, Page DL. Breast cancer risk associated with proliferative disease, age at first birth and a family history of breast cancer. Am J Epidemiol 1987;125:769-79.
15. Shaaban AM, Sloane JP, West CR, et al. Histopathological types of benign breast lesions and the risk of breast cancer. A case-control study. Am J Surg Pathol 2002;26:421-30.
16. Blot WJ, McLaughlin JK. Geographic patterns of breast cancer among American women (editorial). J Natl Cancer Inst 1995:87:1819-20.
17. Peña-Gómez RM. Edad de la menarquia en tres grupos de niñas mexicanas. Departamento de Investigaciones antropológicas. INAH. Publicación 24. México: Secretaría de Educación Pública, 1970.
18. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
19. Brinton LA, Daling JR, Liff JM, et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 1995;87:827-35.
20. Singletary SE. Rating the risk factors for breast cancer. Ann Surg 2003;237:474-82.
21. Rossouw JE, Anderson GL, Prentice RL, et al. Writing group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestins in menopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
22. Barclay L. More evidence linking estrogen plus progestin therapy to breast cancer. JAMA 2003;289:3243-53,3254-63,3304-6.
23. Wynder EL, Cohen LA, Muscat JE, et al. Breast cancer: Weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst 1997;89:766-75.
24. Greenwald P, Sherwood K, McDonald SS. Fat, caloric intake and obesity: Lifestyle risk factors for breast cancer. J Am Diet Assoc 1997;97(suppl):524-30.
25. Vogel VG, Bevers T. Handbook of breast cancer risk-assessment. Evidence-based guidelines for evaluation, prevention, counseling and treatment. Massachusets: Jones & Bartlett Publishers, 2003. ISBN 0-7637-1860-2.
26. World Health Organization Databank.
27. Tominaga S, Kuroishi T, Aoki K. Cancer mortality statistics in 33 countries. Geneva: International Union Against Cancer, 1998.
28. Nagata C, Kawakami N, Shimizu H. Trends in the incidence rate and risk factors for breast cancer in Japan. Breast Cancer Res Treat 1997;44:75-82.
29. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
30. National Cancer Institute. Cancer new web site, available at: www.cancernet.nci,nih.gov
31. Bland KI, Menck HR, Scott-Conner CE, et al. The National Cancer Database. 10 year survey of breast cancer treatment at hospitals in the United States. Cancer 1998;83:1262-73.